HIV shedding in the oral cavity: An assessment of HIV type, immunovirologic,demographic and oral factors

Sexually Transmitted Infections

Volumn 88, Issue 1, 2012, Pages 45-50

  Pavlinac, Patricia B ^a   Hawes, Stephen E ^a   Gottlieb, Geoffrey S ^b   Gaye, Awa ^c   N'Diaye, Charlotte F ^c   Critchlow, Cathy W ^d   Sow, Papa Salif ^c   Feng, Qinghua ^b   Kiviat, Nancy B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MOUTH EXAMINATION; MOUTH LESION; PERIODONTAL DISEASE; PRIORITY JOURNAL; RISK FACTOR; SENEGAL; VIROLOGY; VIRUS DETECTION; VIRUS LOAD; VIRUS SHEDDING; VIRUS STRAIN;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; MOUTH; PERIODONTAL DISEASES; RNA, VIRAL; SENEGAL; VIRAL LOAD; VIRUS SHEDDING; YOUNG ADULT;

EID: 84855882571     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050231     Document Type: Article

References (30)

1. Hawes S, Sow P, Stern J, et al. Lower levels of HIV-2 than HIV-1 in the female genital tract: correlates and longitudinal assessment of viral shedding. AIDS 2008;22:2517-25.
2. Gottlieb GS, Hawes SE, Agne HD, et al. Lower levels of HIV RNA in semen in HIV-2 compared with HIV-1 infection: implications for differences in transmission. AIDS 2006;20:895-900. (Pubitemid 43731572)
3. Liuzzi G, Chirianni A, Clementi M, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996;10:F51-6. (Pubitemid 26394975)
4. Shepard RN, Schock J, Robertson K, et al. Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol 2000;38:1414-18. (Pubitemid 30216664)
5. Delany S, Rosas R, Mlaba N, et al. Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions. J Acquir Immune Defic Syndr 2008;49:406-9.
6. Kiviat NB, Critchlow CW, Hawes SE, et al. Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men. J Infect Dis 1998;177:571-8. (Pubitemid 28099869)
7. Shugars DC, Patton LL, Freel SA, et al. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res 2001;80:414-20. (Pubitemid 32382928)
8. Shugars D, Alexander A, Fu K, et al. Endogenous salivary inhibitors of human immunodeficiency virus. Arch Oral Biol 1999;44:445-53. (Pubitemid 29264464)
9. Shugars D, Slade G, Patton L, et al. Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:432-40.
10. Chebbi F, Poveda J, Suzuki T, et al. Search for infectious HIV in gingival crevicular fluid and saliva of advanced AIDS patients with severe periodontitis. AIDS 1997;11:927-8. (Pubitemid 27226417)
11. Maticic M, Poljak M, Kramar B, et al. Proviral HIV-1 DNA in gingival crevicular fluid of HIV-1-infected patients in various stages of HIV disease. J Dent Res 2000;79:1496-501. (Pubitemid 32489373)
12. Yeung SC, Kazazi F, Randle CG, et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis 1993;167:803-9. (Pubitemid 23088248)
13. Zuckerman R, Whittington W, Celum C, et al. Factors associated with oropharyngeal human immunodeficiency virus shedding. J Infect Dis 2003;188:142-5. (Pubitemid 36829754)
14. Spear GT, Alves ME, Cohen MH, et al. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals. FEMS Immunol Med Microbiol 2005;45:129-36. (Pubitemid 41039996)
15. Barr C, Qureshi M, Qiu Z, et al. Oral HIV-I recovery in the presence of periodontal disease. Oral Dis 1996;2:198-201. (Pubitemid 27005095)
16. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-90. (Pubitemid 24308975)
17. Adjorlolo-Johnson G, De Cock K, Ekpini E, et al. Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast. JAMA 1994;272:462-6. (Pubitemid 24235696)
18. Gottlieb G, Sow P, Hawes S, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002;185:905-14. (Pubitemid 34274433)
19. Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med 2000;160:3286-93.
20. Royston P. Multiple imputation of missing values: update of ice. Stata Journal. 2005b;5:527-36. (Pubitemid 43708457)
21. Lee K, Carlin J. Multiple imputation for missing data: fully conditional specification versus multivariate normal imputation. Am J Epidemiol 2010;171:624-32.
22. Long JS. Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks: Sage Publications, 1997.
23. Interim proposal for a WHO Staging System for HIV infection and Disease. Wkly Epidemiol Rec 1990;65:221-4.
24. Navazesh M, Mulligan R, Kono N, et al. Oral and systemic health correlates of HIV-1 shedding in saliva. J Dent Res 2010;89:1074-9.
25. Ghys P, Fransen K, Diallo M, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997;11:F85-93. (Pubitemid 27421168)
26. Seck K, Samb N, Tempesta S, et al. Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal. Sex Transm Infect 2001;77:190-3. (Pubitemid 32595741)
27. Fultz P. Components of saliva inactivate human immunodeficiency virus. Lancet 1986;2:1215. (Pubitemid 17179058)
28. Fox P, Wolff A, Yeh C, et al. Saliva inhibits HIV-1 infectivity. J Am Dent Assoc 1988;116:635-7.
29. Fox P, Wolff A, Yeh C, et al. Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children. J Am Dent Assoc 1989;118:709-11.
30. Archibald D, Cole G. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses 1990;6:1425-32.